Literature DB >> 27939459

Molecular mechanisms of pruritus.

J Meng1, M Steinhoff2.   

Abstract

Pruritus is an unpleasant sensation that evokes the urgent desire to scratch. It is a symptom derived from many nervous system disorders that affects a large population of humans and is treated by a variety of pharmacological agents with variable access. Chronic itch is a huge unmet health problem which affect upward 20% of people worldwide. The mechanisms underlying the chronic pruritus are complex. Studies of the neurobiology, neurophysiology and cellular biology of itch have gradually been clarifying the mechanism of chronic itch both peripherally and centrally. The discussion has been focused on pruriceptive nerves and their receptors as well as the cytokines/chemokines that play major roles in itch induction. Though it is historically hypothesized that pain convey signal generated with the stimuli under high intensity, and itch transduces signal from the same nerves of pain but under low intensity, recently, with the identification of distinct itch specific sensory afferent fibers the theory has twisted the "intensity" to a existence of a complete separation of pain and itch pathways. This review helps to understand the unique properties of itch signaling pathways and their clinical importance of the itch perception and pruritic diseases.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Endothelin-1; Itch; Neuropeptide receptor; Protease-activated receptor; Pruritogens; Sensory nerves; Signal transduction; Translational medicine

Mesh:

Substances:

Year:  2016        PMID: 27939459     DOI: 10.1016/j.retram.2016.08.006

Source DB:  PubMed          Journal:  Curr Res Transl Med        ISSN: 2452-3186            Impact factor:   4.513


  16 in total

Review 1.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-11-06       Impact factor: 84.694

2.  JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

Authors:  Daniella M Schwartz; Yuka Kanno; Alejandro Villarino; Michael Ward; Massimo Gadina; John J O'Shea
Journal:  Nat Rev Drug Discov       Date:  2017-12-28       Impact factor: 84.694

Review 3.  Pathophysiology of Itch.

Authors:  Ethan A Lerner
Journal:  Dermatol Clin       Date:  2018-03-20       Impact factor: 3.478

Review 4.  The Neuroimmune Axis in Skin Sensation, Inflammation, and Immunity.

Authors:  Anna M Trier; Madison R Mack; Brian S Kim
Journal:  J Immunol       Date:  2019-05-15       Impact factor: 5.422

5.  Cinnamaldehyde elicits itch behavior via TRPV1 and TRPV4 but not TRPA1.

Authors:  Dan Domocos; Taylor Follansbee; Amanda Nguyen; Tony Nguyen; Mirela I Carstens; Earl Carstens
Journal:  Itch (Phila)       Date:  2020-07-24

Review 6.  [Importance of phototherapy in the treatment of chronic pruritus].

Authors:  Franz J Legat
Journal:  Hautarzt       Date:  2018-08       Impact factor: 0.751

Review 7.  Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.

Authors:  Kinga Fanni Tóth; Dorottya Ádám; Tamás Bíró; Attila Oláh
Journal:  Molecules       Date:  2019-03-06       Impact factor: 4.927

Review 8.  Pruritus: Progress toward Pathogenesis and Treatment.

Authors:  Jing Song; Dehai Xian; Lingyu Yang; Xia Xiong; Rui Lai; Jianqiao Zhong
Journal:  Biomed Res Int       Date:  2018-04-11       Impact factor: 3.411

9.  The impact of medium dose UVA1 phototherapy on pruritus, DLQI and SCORAD index in patients with atopic dermatitis.

Authors:  Karolina Malinowska; Anna Woźniacka; Jarosław Bogaczewicz
Journal:  Postepy Dermatol Alergol       Date:  2019-10-07       Impact factor: 1.837

Review 10.  Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.

Authors:  Jianghui Meng; Yanqing Li; Michael J M Fischer; Martin Steinhoff; Weiwei Chen; Jiafu Wang
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.